| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |